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We performed a prospective, randomised controlled
trial to assess the differences in the use of a conven-
tional suction drain, an Autologous Blood Trans -
fusion (ABT) drain and no drain, in 168 patients.
There was no significant difference between the
drainage from ABT drains ( mean : 345 ml) and the
suction drain (314 ml). Forty percent of patients
receiving a suction drain had a haemoglobin level less
than 10 g/dL at 24 hours, compared to 35% with no
drain and 28% with an ABT drain. Patients that had
no drains had wounds that were dry significantly
sooner, mean 3.0 days compared to a mean of 3.9 days
with an ABT drain and a mean of 4 days with a suc-
tion drain. Patients that did not have a drain inserted
stayed in hospital a significantly shorter period of
time, compared with drains. We feel the benefits of
quicker drying wounds, shorter hospital stays and the
economic savings justify the conclusion that no drain
is required after hip replacement. 
Keywords : hip replacement ; autologous transfusion ;
drain.
INTRODUCTION
in 2008, orthopaedic surgeons working in NHS
Trusts in England and Wales performed approxi-
mately 64 700 total hip replacements (THRs) (9). in
the absence of blood saving measures, blood loss
per uncomplicated THR has been estimated at
1550-2400 mls (17) and on average, 48% of patients
receive an allogenic blood transfusion (8,27).
Allogeneic blood transfusion is considered to be
safe but is not free of complications and carries a
small degree of risk. in the United Kingdom, the
estimated frequency of infectious donations enter-
ing the blood bank during 1996-2003 was 1.66,
0.80 and 0.14 per million for HBV, HCV and HiV
respectively (31). Use of allogeneic blood gives an
increased rate of post-operative infection (11,14,22 )
and has been shown to prolong hospital stay by 2
days (22). Use of allogeneic blood should therefore
be avoided unless absolutely necessary.
Drains are used with the intent of preventing
haematoma accumulation and decreasing the likeli-
hood of prolonged wound drainage, healing, or
infection (2). A meta-analysis has confirmed that the
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use of closed suction drains reduced the need for
wound dressings but also found that suction drain
use actually increased blood transfusion require-
ments (24).
More recently the use of autologous transfusion
drains has been analysed, although the literature
includes retrospective reviews of data (12,32) and
the grouping of data for both hip and knee arthro-
plasty (15,20,32,37) or all orthopaedic surgery (5).
Two recent randomized controlled trials have com-
pared the use of autologous transfusion drains and
suction drains after hip arthroplasty (29,30). One trial
found no significant difference in mean post-opera-
tive haemoglobin (Hb) levels but did find a signifi-
cantly lower allogeneic blood transfusion rate for
patients with a reinfusion drain (30), whereas the
other trial found significantly higher post-operative
Hb levels in patients with a reinfusion drain but no
difference in allogeneic blood transfusion rates (29).
To our knowledge, so far only one study has
compared between the three alternatives, namely a
suction drain, a reinfusion drain or no drain (26).
That study found no significant differences in post-
operative Hb levels or allogeneic transfusion rates
between the groups. All patients in that study had
donated at least two units of autologous blood
before the operation, which was routinely rein-
fused, resulting in a very low allogeneic blood
transfusion rate of 3.3%. pre-operative autologous
blood donation is however not common practice
(27) and has not been found to be cost-effectve
(3,10). We therefore performed a prospective, ran-
domised controlled trial to assess the difference
between the use of a conventional suction drain, an
autologous transfusion drain and no drain, on the
rate of allogeneic blood transfusion and Hb levels.
Secondary outcome measures included time until
the wound became dry, differences in length of hos-
pital stay and wound infection rates.
PATIENTS AND METHODS
The trial was approved by our local ethics
research committee. power calculation for a χ2-test
suggested that 42 patients per group would be
required to detect that patients in one group would
have a 15% larger risk than the other two groups to
require a blood transfusion, based on the transfu-
sion risk after hip surgery of 11% in our hospital
(effect size 0.28, power 80%, p-value of 0.05). We
studied a minimum of 50 patients per group to
allow for drop out and loss to follow-up. 
Between July 2005 and August 2006,
168 patients having primary total hip replacements
for osteoarthritis were recruited into the trial.
informed consent was obtained. These patients
were under the care of three different consultants
who used an identical posterior approach to the
hip. The exclusion criteria included the presence
of clotting disorders, current anticoagulation and a
previous thromboembolic event. 
All patients had their pre-operative haemoglobin
checked. A dose of Cefuroxime 1.5 g was given at
induction of anaesthesia and a second dose 8 hours
following surgery. The choice of hip replacement
components was independently made by the operat-
ing surgeon.
patients were randomised pre-operatively into
one of three groups using stratified randomisation
software to balance the groups with respect to
potentially confounding factors (StratOs, Cooked
Bits, Oswestry, UK). This software used the pocock
and Simon implementation of the minimization
method (20). We used four prognostic factors for the
stratification : age, gender, Body Mass index (BMi)
and use of aspirin and non-steroidal anti-inflamma-
tory drugs (NSAiDs).patients were allocated into
one of three groups : autologous blood transfusion
(ABT), a standard suction drain and no drain. All
drains used a single size 12 drain, placed deep to the
fascia lata. The ABT group received a Bellovac
ABT (Astra Tech ltd, Gloucestershire, UK) and the
vacuum drains were High Vacuum Medinorm type,
(Van Straten, Quiershield, Germany). if deemed
necessary, patients in the ABT group received an
autologous transfusion of their own drain blood
within 6 hours of collection as per the manufactur-
er’s instructions. All drains were removed at
24 hours post surgery. 
All patients received identical post-operative
care aiming for early mobilisation and discharge
home. Thromboprophylaxis consisted of a once
daily dose of 150 mg of Aspirin for 6 weeks and a
proton pump inhibitor. Further mechanical throm-
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boprophylaxis consisted of foot pumps and below
knee thromboembolic deterrent stockings (Tyco
Healthcare, Gosport, UK). postoperative mobilisa-
tion was commenced as soon as tolerated and when
any spinal anaesthesia had worn off. 
The decision on whether or not to transfuse was
made by the ward doctors or anaesthetist. No crite-
ria were set to trigger a transfusion, although all
doctors at the trust had attended a transfusion
awareness lecture, outlining broad guidelines.
Decisions were to be made on an individual basis
according to symptoms, previous history of cardio-
vascular and cerebrovascular disease and haemo-
globin level. Discharge was only permitted once the
wound was dry and the patient was safe to mobilise.
The type of prosthesis, use of non-steroidal anti-
inflammatory drugs, levels of haemoglobin (Hb)
and haematocrit (HCT), length of hospital stay, the
type of anaesthetic, and the number of days till the
wound became dry, (including drain site), prior to
discharge were recorded. At a six-week outpatient
appointment investigation and treatment for throm-
boembolic events, positive wound swab cultures
and the use of antibiotics in the community were
noted.
The primary outcome measure for the trial was
the transfusion rate (the proportion of patients that
received blood transfusion) and the volume of
blood administered. Secondary outcome measures
were postoperative level of Hb, wound infection
rate, time of wound to become dry and length of
hospital stay. Categorical data were compared
between the three groups using Fisher’s exact test.
Since most continuous variables had a non-normal
distribution, all continuous variables were com-
pared between the three groups using the Kruskal-
Wallis test. However, to adjust for the influence
of age, BMi and pre-operative levels, we used
Analysis of Covariance (ANCOVA) to compare
volumes of blood, Hb levels and haematocrit levels
between the groups, Generalized Linear Modelling
(GLM) with a log link function to analyze differ-
ences between the groups in volume of transfused
blood and length of hospital stay, and logistic
regression to compare the odds of requiring a trans-
fusion between the groups. GLM is a statistical
analysis method particularly suited to cope with
data that has a non-normal distribution by using a
link function that transforms the mean of outcome
variable (18). The log-link function is the appropri-
ate transformation to analyse count data (18).
Although ANCOVA is robust against deviations
from normality (23), a GLM with a log link function
is more suited to analyze data that is extremely
skewed, such as length of stay. Relative risks of
requiring a transfusion, adjusted for covariates,
were calculated from the odds ratios determined by
logistic regression (38). For all analyses comparing
three groups, Tukey’s HSD was used as a post-hoc
test. All analyses were based on the intention to
treat principle. A p-value of 0.05 or less was
assumed to denote significance. All statistical
analyses were performed using R version 2.8.1 (R
Foundation for Statistical Computing) and SYSTAT
version 11 (SYSTAT Software inc., Richmond, CA,
USA).
RESULTS
Of the 168 patients consented for the trial and
randomised, 153 patients were actually entered in
the study after exclusion criteria were re-checked.
There were 53 patients in the ABT group, 52 in the
suction drain group and 48 in the no drain group.
The three groups were comparable in terms of gen-
der distribution, NSAiD use, pre-operative levels of
Hb and HCT, anaesthetic used and implant type
inserted (table i). However, despite the use of strat-
ified randomization to balance the groups, age and
BMi differed significantly between them (table i).
For this reason, we used these two variables as
covariates in our further analyses. 
Median intra-operative blood loss was identical
among the three groups, and increased significantly
with BMi (table ii). patients with an ABT drain had
a 14% smaller median drain volume than those with
a suction drain, a non-significant difference (table
ii). Thirty-one (58%) patients in the ABT group
received an autologous reinfusion with a median
volume of 250 ml. The median reinfusion volume
averaged over all patients in the group was 150 ml
(table ii). in a logistic regression, drainage volume
was the only significant variable predicting whether
a patient would receive an autologous reinfusion 
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(p = 0.01). patients who received a reinfusion had a
significantly larger drainage volume than patients
who did not (350 vs 200 ml, p < 0.001, Mann-
Whitney test). 
Five times more patients with a suction drain than
those without drain needed an allogeneic transfusion
within 24 hours, and they required four times more
units of allogeneic blood, both significant differ-
ences (table ii and iii). The allogeneic transfusion
requirements of the patients in the ABT group were
between the other two groups (table i and iii).
Higher age and lower BMi were associated with
increased transfusion requirements (table ii). The
haemoglobin levels 24 hours after the operation,
adjusted for pre-operative levels, were similar for all
three groups, and larger for patients with larger BMi
(table ii). Haematocrit levels adjusted for pre-op
levels were also similar (table ii). Allogenic trans -
fusion requirements after 24 hours and haemoglobin
levels at 72 hours were similar for the three groups
(table ii and iii). Analyzed over the total period,
patients with a suction drain were three times as like-
ly to receive an allogeneic transfusion than those
without a drain, a significant difference, with the
allogeneic transfusion requirements for patients with
a reinfusion drain between the two (table ii and iii). 
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Table i. pre-operative patient characteristics and details of anaesthetics and implant type for the three groups*
* Values of continuous variables are given as median (iQR). p-values for differences between the three groups were calculated using
the Kruskal-Wallis test for continuous data or Fisher’s exact test for categorical data.
Reinfusion drain (n = 53) Suction Drain (n = 52) No Drain (n = 48) p-value
BMi 29 (26-33) 26.3 (24.3-29.5) 27 (25-29) 0.034
Age (Years) 65 (61-73) 70.5 (63-76) 69 (62.3-76) 0.054
Sex (M/F) 22/39 24/30 23/30 0.60
pre-op use of Aspirin/NSAiDs 0.11
Aspirin 6 12 6
NSAiDs 13 19 17
Both 5 6 2
None 29 15 23
pre-op Hb (g/dl) 13.6 (13.0-14.4) 13.7 (12.7-14.3) 14.0 (12.9-14.8) 0.55
pre-op HCT (%) 39.6 (37.9-42.7) 39.2 (36.5-41.5) 40.7 (37.9-42.7) 0.16
Type of Anaesthetic 0.33
GA 11 15 14
GA + regional 16 12 6
GA + spinal 5 2 5
GA + epidural 5 9 4
Spinal 14 9 15
Epidural 0 1 2
Spinal + regional 1 2 1
Femoral Component 0.78
Uncemented 11 8 8
Cemented 42 44 40
Acetabular component 0.42
Uncemented 27 36 35
Cemented 21 17 17
Because not all patients with a reinfusion drain
received an autologous transfusion, we also com-
pared the allogeneic transfusion risk between the
31 patients in this group who did and the 22 who
did not receive an autologous transfusion. in all, 3
of the 31 patients who did and 6 of the 22 patients
who did not receive an autologous transfusion
needed an allogeneic transfusion, translating in a
relative risk of 0.3 (0.06-1.1). 
patients who did not have a drain stayed on aver-
age a day less in hospital than those with a suction
drain, a significant difference (table ii). Although
their wounds were also dry a day earlier, this differ-
ence was not significant according to the Tukey
HSD test (table ii). The length of stay and number
of days for the wound to dry for patients in the ABT
group was between those in the two other groups
(table ii). Using a generalized model, we found that
age and having had an allogeneic transfusion were
the strongest predictors of hospital stay (p < 0.001
for each). Older patients stayed in hospital signifi-
cantly longer (table ii).
Two patients in the suction drain group had a
superficial wound infection. One patient was treat-
ed with oral antibiotics by the general practioner,
and the second was admitted seven months post-
operatively with cellulitis around the wound. None
of the patients in the other groups had an infection.
Due to the small number of infections no significant
difference between the three groups of patients
could be detected.
Four patients developed post-operative medical
complications : One patient developed a pulmonary
embolus, one a myocardial infarction and one
developed pancreatitis. One patient in the suction
drain group died of multi-organ dysfunction. No
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Table ii. - intra-operative and post-operative outcomes for the three groups*
Reinfusion drain 
(n = 53)
Suction drain 
(n = 52)
No drain 
(n = 48)
p-value
intra-op blood loss (ml)1 300 (200-458) 300 (200-400) 300 (250-350) 0.40
Drained volume (ml) 300 (200-400) 350 (113-558) - 0.22
Re-infused volume (ml) 150 (0-250) - - -
post-op transfusion within 24
hours1,2
5 ptnts (9%)a,b
(10 units)a,b
15 ptnts (29%)a
(22 units)a
3 ptnts (6%)b
(5 units)b
0.01 
0.02
Hb at 24 hours (g/dl)1 10.5 (9.5-11.5) 10.5 (9.3-11.4) 10.4 (9.5-11.5) 0.87
HCT at 24 hours (%) 30.6 (27.9-33.6) 30.0 (27.0-33.2) 30.0 (27.1-33.4) 0.98
post-op transfusion after 24 hours 4 ptnts (8%) 
(8 units)
7 ptnts (13%) 
(14 units)
3 ptnts (6%) 
(6 units)
0.46 
0.46
Hb at 72 hours (g/dl) 10.1 
(9.2-12.0)
10.5 
(9.2-11.2)
10.5 
(9.4-11.3)
0.60
Overall transfusion2 9 ptnts (17%)a,b
(18 units)
19 ptnts (37%)a
(36 units)
6 ptnts (13%)b
(11 units)
0.02 
0.04
Wound drying (days) 3 (2-5)a 4 (2-5)a 3 (2-4)a 0.04
Hospital length of stay (days)2 6 (5-8)a,b 7 (5.3-9)a 6 (5-7)b 0.03
* Values for continuous variables are given as median (iQR). p-values for differences between the three groups were calculated
using ANCOVA for volumes, Hb levels and HCT level, GLM with log link function for days and number of transfusion units, and
logistic regression for number of patients requiring transfusion. ANCOVA, GLM and logistic regression used age, BMi and pre-
operative levels of Hb or HCT as covariates. 
1) Significantly associated with BMi. 
2) Significantly associated with age. 
a,b) Means with the same letter do not differ significantly according to the Tukey HSD follow-up test. Means with differing letters
differ significantly (p < 0.05).
patients required re-operation and there has been no
clinical or radiological evidence of deep infections
at 12 months post-op.
DISCUSSION
in this prospective randomized controlled trial
comparing two types of drainage and no drains, the
immediate post-op allogeneic transfusion rate was
three times higher in patients who had a suction
drain compared to patients who had no drain. The
median length of hospital stay of patients fitted with
a suction drain was also significantly higher (1 day)
than that of patients who had no drain. There was
no significant difference in terms of allogeneic
blood transfusion requirement or length of stay
between patients who had a reinfusion drain fitted
and the other two groups of patients. We found no
significant difference in post-operative haemoglo-
bin levels between the three groups, neither 24 nor
72 hours after the operation.
The finding in this study that patients with a suc-
tion drain were significantly more likely to receive
an allogeneic blood transfusion than those without
a drain echoes the findings of a meta-analysis (24).
The relative risk found in the present study is about
twice the average reported in that meta-analysis
(3.0 vs 1.43). This difference is mainly due to the
low risk of transfusion in the absence of a drain in
our study (13%) compared to the average for that
group in the meta-analysis (28%). 
The relative risk of an allogeneic blood transfu-
sion for patients with a reinfusion drain was
between the other two groups and did not differ sig-
nificantly from either. The relative transfusion risk
of 1.7 for suction drains relative to reinfusion drains
is comparable to the combined relative risk of 2.2
for orthopaedic procedures in a recent meta-analy-
sis (5), and very close to the 1.6 in a recent trial of
suction drains versus reinfusion drains in hip sur-
gery (29). The lower transfusion risk for patients
with an autologous transfusion drain was achieved
despite the fact that only 58% of patients with an
ABT drain received a reinfusion. Such a relatively
low reinfusion rate is not uncommon. For instance,
in a recent randomized trial comparing between
suction drains and reinfusion drains, only 66% of
patients randomized to the reinfusion arm actually
received a reinfusion (29). The reason for the low
reinfusion rate in our study was most likely the
small volume of drained blood in some patients. An
additional factor may have been time expiry of the
drained blood. According to the manufacturer’s
instructions blood collected in an ABT drain must
be re-infused within 6 hours of surgery. Unfor tu -
nately, we were unable to find out if any patients in
our study did not receive a reinfusion due to the
drained blood being time expired. interestingly, in
our study the risks of allogeneic blood transfusion
were 0.097 in the reinfused patients and 0.27 in the
non-reinfused patients (RR = 2.8). Although this
difference was not significant, it would be useful to
conduct a trial to find out if it were beneficial to
always attempt reinfusion. 
in addition to the increased transfusion require-
ments, we also found that patients with a suction
drain had a significantly longer median length of
hospital stay than patients with no drain (7 versus
6 days, respectively). However, a meta-analysis
reported that none of the seven included studies that
analysed length of hospital stay found a difference
(24). Most likely, the significant difference in length
of stay found in our study is simply a reflection of
either, the large difference in transfusion rates
between the groups we found or the greater amount
of time it took for their wounds to become dry. in a
large European survey, patients who required an
allogeneic transfusion had a significantly larger
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* Adjusted risks based on logistic regression and confidence limits based on Tukey HSD follow-up test
Table iii. — Relative risk of allogenic blood transfusion, with 95% Ci, adjusted for BMi and age*.
Drainage Group RR within 24 hrs RR after 24 hrs RR overall
Reinfusion vs No
Suction vs No
Suction vs Reinfusion
2.5 (0.58-7.6) 
5.0 (1.6-10.4) 
2.2 (0.77-4.9)
1.3 (0.28-4.7) 
2.1 (0.57-6.2) 
1.6 (0.49-4.3)
1.8 (0.67-3.9) 
3.0 (1.4-5.1) 
1.7 (0.79-3.1)
length of stay than those who required no or an
autologous transfusion (27). in our study, having an
allogeneic blood transfusion was also a significant
predictor of length of stay. The longer stay of
patients requiring allogeneic transfusions is thought
to be related to disturbances in wound healing (35).
in line with that study, we did indeed find that
patients who required an allogeneic transfusion had
longer wound drying times (data not shown). The
longer hospitalization of patients with a suction
drain may be related to the longer time taken for
the wounds to dry in that group. Length of hospital
stay is multifactorial and can be influenced by other
factors including post-operative pain, social cir-
cumstances and the view of the surgeons and
patients. 
We found no difference in length of hospital stay
between patients with a reinfusion drain and those
with no drain. As mentioned above, this lack of a
difference is most likely related to the smaller dif-
ference in allogeneic transfusion risk between these
two groups, and the ensuing smaller difference in
wound healing disturbances. Wound healing distur-
bances may be related to an allogeneic transfusion,
and not to drain usage per se. Drains are used in hip
surgery because they theoretically reduce the risk of
wound haematomas and infection. However, a
meta-analysis of 18 studies with 3495 patients
failed to find evidence for this (24). Our finding that
drainage from the wound increased with drain use
may in part be related to continued drainage from
the drain site, once the drain was removed. Our
finding is otherwise somewhat counterintuitive and
should be interpreted with caution, although not
without precedent. Cobb found that the use of a
drain after hip fracture surgery was associated with
late wound leakage (7). Dora et al found that those
patients that had a drain had persistent drainage for
an average 1.5 days longer than those without (8).
Since wound infection is such a rare event in hip
surgery (in our study it was 1.3%), a very large
clinical trial would be needed to find out if drain
usage reduces infection rates. Based on the average
infection rate of 4.5% in the meta-analysis, such a
study would require 750 patients in each group to
demonstrate a difference in risk of 3% (3% vs. 6%)
between the two groups. 
There is no clear evidence that wound drainage is
associated with reduction of haematoma formation.
Wildman et al found no statistical difference in
haematoma size on nuclear medicine scanning in
their total hip replacements (36). Significant surgery
results in the formation of a dead space which is not
decreased by suction drainage as the tissues are not
mobile enough. This space, therefore, has to fill
with blood until a tamponade effect is achieved.
This potential space is of the same volume
whether drainage is used or not. The use of
closed suction drainage merely serves to increase
this potential dead space by the volume evacuated
by the drain (21).
There was no significant difference in levels of
haemoglobin (Hb) at 24 and 72 hours or haemat-
ocrit (HCT) at 24 hours between the three groups.
The differences in transfusion rates are therefore
not explained by differences in post-operative Hb
or HCT levels. 
One weakness of this study is the lack of a strict
transfusion trigger. Although recommended algo-
rithms are available (13), the hospital’s peer review
board felt it important to treat each patient and their
requirement for allogeneic blood on an individual
basis. That haemoglobin levels post-operatively
were similar between groups would suggest that the
decision to transfuse was not based on Hb alone,
but on risk factors and symptoms. The greater rate
of transfusion in the suction drain group may in part
be explained by the visible cue provided by blood
in the drain and the knowledge that this blood
will not be given back to the patient. Transfusion
rates in total knee replacement vary between 6 (16)
and 95% (19). This illustrates the heterogeneity of
policies or simply of behaviours of clinicians with
respect to blood transfusion. The decision to trans-
fuse has a subjective component which can never
be completely erased, which may reduce the relia-
bility of transfusion rate as an outcome measure.
A second weakness in our study design is the
lack of blinding to drain use by the operating sur-
geon. This is a common weakness of studies com-
paring the use of suction drains and reinfusion
drains (5). in our study, surgeons were informed of
the patient’s study group prior to commencing sur-
gery. Although this may have influenced the degree
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of diathermy haemostasis performed, surgeons
were advised to use equal scrutiny for all three
groups. The absence of a significant difference in
intra-operative blood loss suggests that the absence
of blinding will not have influenced the outcome of
the study through its effect on haemostasis. For
future research this bias may be minimised by hav-
ing the surgeon leaving the operating room and
have the wound closed by a surgical assistant and
the drain inserted as per randomisation. At our unit
surgeons wanted to close the wounds themselves
and so this method could not be used.
The intermittent clamping of drains after total
hip replacement has been suggested as a method of
reducing transfusion rates by producing a tampon-
ade, but allow prevention of haematoma formation.
Brueggemann et al used clamping of the drain for
55 minutes every hour for 6 hours after hip replace-
ment to reduce drainage. This reduced calculated
blood loss and transfusion requirements (4). On the
other hand, Clifton et al in their randomised trial,
showed no benefit in clamping a drain for 1 hour
rather than immediate release post-operatively (6).
Clamping was not performed in our study to avoid
the addition of a further variable and reducing the
effective sample size for each population. Other
suggested methods of reducing blood transfusion
have previously been summarised elsewhere (17),
which were not formally investigated for the pur-
poses of this study, but should also be considered in
practice.
To our knowledge, this is the first study to
prospectively compare all three wound drainage
options available to surgeons, namely a reinfusion
drain, a standard suction drain and no drain, in a
population of patients undergoing total hip replace-
ment who have not donated autologous blood pre-
operatively. We found that using a suction drain
significantly increased risk of allogeneic blood
transfusion and length of hospital stay, compared to
using no drain. We found no significant difference
between using a reinfusion drain and using no drain
in the rate of allogeneic blood transfusion or the
length of hospital stay, and therefore feel that
those reasons cannot justify the use of a drain.
Whether the use of a reinfusion drain can reduce
the occurrence of wound complications will require
a much larger study than ours was. This study,
together with other previously published data
would suggest that there is no benefit in using a
non-transfusion suction drain. A further much
larger study is required to define if there is any
benefit of an autologous transfusion drain over no
drain at all.
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